Znanost

Radovi objavljeni u časopisima koji se indeksiraju u Current Contentsu

1.    Cvitanović S, Grbić D, Zekan Lj, Boban M., Vrdoljak E, Parpura V, Petrović S, Marušić M. Hypersensitivity to P. Officinalis pollen: Correlation of IgE with skin testing methods. Allergol et Immunopathol 1989:17;4:197-200.
2.    Cvitanović S, Marušić M, Juričić M, Vrdoljak E, Petrovečki M, Rozga A, Stavljenić-Rukavina A. Hypersensitivity to Parietaria Officinalis pollen in the newcomers to the area with the plant. Allergy 1993:48;592-597.
3.    Bill CA, Grochan BM, Vrdoljak E, Mendoza EA, Tofilon P. Decreased repair of radiation-induced DNA double-strand breaks with cellular differentation. Rad Res 1992:132;254-258.
4.    Vrdoljak E, Bill CA, Stephens LC, van der Kogel AJ, Kian Ang K, Tofilon PJ. Radiation induced apoptosis of oligodendrocytes in vitro. Int J Radiat Biol 1992:62;4;475-480.
5.    Bill CA, Mendoza E, Vrdoljak E, Tofilon PJ. Enhancment of tumor cell killing in vitro by pre- and post-irradiation expossure to aclacinomycin A. Radiotherapy and Oncol 1993:28;63-69.
6.    Vrdoljak E, Miše K, Rozga A, Sapunar D, Marušić M. Survival analysis of untreated patients with non-small lung cancer. Chest 1994;106:1797-81.
7.    Vrdoljak E, Bill CA, Stepens LC, Borchardt PE, Tofilon PJ. Influence of X-rays on early response gene expression in rat astrocytes and brain tumor cell lines. Int J Radiat Biol. 1994:66;6:739-747.
8.    Sapunar D, Bego K, Pintarić I, Vrdoljak E, Petri N, Saraga-Babić M. Effect of maternal hyperoxygenation on the experimentally produced uteroplacental insufficiency in rat. Reprod Fertil Dev 1996:8;379-381.
9.    Vrdoljak E, Milas L. Apoptosis: Basic biology and relationship to cancer. CMJ 1996:37;141-151.
10.    Krolo M, Vilović K, Sapunar D, Vrdoljak E, Saraga-Babić M. Fibronectin Expression in the developing human spinal cord, nerves and ganglia. CMJ 1998:39;386-391.
11.    Vrdoljak E, Miše K, Sapunar D, Rozga A, Marušić M. Staging of untreated patients with   small cell lung cancer. Neoplasma 2001;48:155-157.
12.    Phan TP, Crane CH, Janjan NA, Vrdoljak E, Milas L, Mason KA. WR-2721 Reduces Intestinal Toxicity from Concurrent Gemcitabine and Radiation Treatment. Int J of Pancreatol 2001;29:45-50
13.    Vrdoljak E, Hamm W, Omrčen T, Prskalo T. Long lasting complete remission of a patient with cervical cancer FIGO IVB treated by concomitant chemobrachyradiotherapy with ifosfamide and cisplatin and consolidation chemotherapy – A case report. European Journal of Gynacelogical Oncology. 2004;25:247-249.
14.    Vrdoljak E, Hamm W. Current state-of-the-art of concomitant chemoradiation in cervical carcinomas. Euopean Journal of Gynacelogical Oncology 2003;26:475-481.
15.    Kristensen GB. Vergote I. Stuart G. Del Campo JM. Kaern J. Lopez AB. Eisenhauer E. Aavall-Lundquist E. Ridderheim M. Havsteen H. Mirza MR. Scheistroen M. Vrdoljak E. First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin. International Journal of Gynecological Cancer. 13(Suppl 2):172-177, 2003 Nov-Dec.
16.    Vrdoljak E, Prskalo T, Frleta Ilić N, Omrčen T, Janković S, Hamm W. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma (LASCC) of the cervix uteri – Results of a phase II study. International Journal of Radiation Biology Oncology Physics 2005;61:824-829.
17.    Vrdoljak E, Boraska Jelavić T, Saratlija Novaković Ž, Hamm W. Concomitant Chemobrachyradiotherapy with Ifosfamide and Cisplatin Followed by Consolidation Chemotherapy in the Treatment of Locally Advanced Adenocarcinomas or Adenosquamous Carcinomas of the Cervix Uteri. European Journal of Gynacelogical Oncology 2005;6:602-604.
18.    Grubišić Čabo F, Vrdoljak E. Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly whom had been administered gemfibrozil in therapy. Medical Oncology, Med Oncol. 2006;23(1):121-4..
19.    Čufer T, Vrdoljak E, Gaafar R, Ernesoy I, Pemberton K. Results from a phase II, open-label, randomized study (SIGN) comparing gefitinib (iressa) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. Anticancer Drugs 2006;17:401-409.
20.    Vrdoljak E, Boban M, Saratlija-Novakovic Z, Jovic J. Long-lasting partial regression of a patient with glioblastoma multiforme achieved using edotecarin – a case report, Croat Med J. 2006 Apr;47(2):305-9.
21.    Boraska Jelavić T, Barišić M, Drmić I, Boraska V, Vrdoljak E, Peruzović M, Hozo I, Puljiz Z, Terzić J. Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin Genet 2006;70:156-60.
22.    Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
Coleman RE, Banks LM, Girgis SI, Kilburn LS, Vrdoljak E, Fox J, Cawthorn SJ, Patel A, Snowdon CF, Hall E, Bliss JM, Coombes RC; Intergroup Exemestane Study group.
Lancet Oncol. 2007 Feb;8(2):119-27
23.    Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O, Cufer T, Dixon JM, Maass N, Marchetti P, Pagani O, Pronzato P, Semiglazov V, Spano JP, Vrdoljak E, Wildiers H.
Breast. 2009 Feb;18(1):2-7. Epub 2008 Nov 26. Review
24.    Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Nieto A, Yuan J, Bukowski R.
Lancet Oncol. 2009 Aug;10(8):757-63. Epub 2009 Jul 15.


Radovi objavljeni u časopisima koji se indeksiraju u drugim međunarodnim indeksnim publikacijama

1.      Cvitanović S, Grbić D, Zekan Lj, Petrović S, Vrdoljak E, Parpura V, Boban M. Ketotifen and  
     nasal steroid in hay fever pollinosis. Res Disease 1989:41;205-208.
2.      Tofilon P, Vrdoljak E, Kian Ang K. Investigation of central nervous system radiobyology  
            using glial cell cultures. Cancer Bull 1992:44;92-97.
3.     Vrdoljak E. Chemotherapy and Radiotherapy of Colon and Rectal Carcinoma. Libri Oncologici
           2001;29:30-40.
4.     Vrdoljak E,  Glavina Durdov M, Kuzmić Prusac I, Tomić S, Rozga A, Petrić Miše B, Alfirević D, Bezić J, Forenpoher G, Karaman I, Pešutić Pisac V, Rakanović S. Correlation between standard IHC method and HercepTest in detection of HER2/neu overexpression in breast cancer.Libri Oncologici 2001;29:8-12.
5.      [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome]
Krznarić Z, Juretić A, Samija M, Dintinjana RD, Vrdoljak E, Samarzija M, Kolacek S, Vrbanec D, Prgomet D, Ivkić M, Zelić M; Croatian Society of Parenteral and Enteral Nutrition, Croation Society of Oncology, Croation society of Medical Oncology, Croation Medical Association. Lijec Vjesn. 2007 Dec;129(12):381-6. Croatian.
6.        Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients. Vrdoljak E, Omrcen T, Boban M, Hrepic D. J BUON. 2008 Oct-Dec;13(4):513-8.
7.        [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting] Tomek R, Vrdoljak E, Vrbanec D, Nemet D, Matković V, Plestina S, Gugić D, Dintinjana RD, Bolanca A, Samarzija M, Petković M. Lijec Vjesn. 2009 Mar-Apr;131(3-4):49-53. Croatian.

Ostali radovi

1.    Vrdoljak E, Omrčen T, Mikuš S, Petrić-Miše B. Karcinom jajnika. Medicus, 2001;10:207-11.
2.    Vrdoljak E, Boban M, Ilić-Frleta N. Suvremeni pristup liječenju karcinoma vrata maternice. Medicus, 2001;10:211-4.

Udžbenici, poglavlja u udžbenicima

1.     J. Bilić, E. Vrdoljak. Probavni sustav, u Radioterapija, ur. M. Šamija, Z. Krajina i A. Purišić, Nakladni Zavod Globus, Zagreb, 1996, 263-275.
2.     J. Bilić, E. Vrdoljak. Radioterapija tumora probavnog sustava, u Radioterapija gdje-kada-kako, ur. M. Šamija, Z. Krajina i I. Voskrsenski, Medicinski Fakultet Sveučilišta u Zagrebu, Katma, Zagreb, 1993, 44-50.
3.     E. Vrdoljak. Tumori jetre, u Odabrana poglavlja iz gastroenterologije, ur. I. Hozo i S. Miše, DES, Split, 1999, 303-313.
4.     E. Vrdoljak. Konkomitantna kemoradioterapija, u Internistička onkologija., ur. Z. Krmpotić Mršić, Medicinska naklada, Zagreb, 2004.
5.     Klinička onkologija. M. Šamija, E. Vrdoljak, Z. Krajina. Medicinska naklada, Zagreb, 2005. Ispiši stranicu